Cancer Family

Lymphocytic Neoplasm

HematologicNon-malignant3,037 active trials72 approved drugs345 evidence items

NCIt: C7065

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (351)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 51–75 of 351 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma.
Olivia Febvey-Combes, Cédric Rossi, Behrouz Kassai et al. · Clin Pharmacol Ther · Sep 7, 2026 · PMID 42704204 · candidate dictionary pubmed
Comment on "Exceptional long-term responses from OCEAN and HORIZON trials: melflufen-dexamethasone as an expansion of treatment options for relapsed/refractory multiple myeloma in the era of new immunotherapies?".
Manish R Bhise, Akshay Akotkar, Shweta Bhandari et al. · J Cancer Res Clin Oncol · Sep 7, 2026 · PMID 42706433 · candidate dictionary pubmed
Circulating tumor cells identify a disseminated genomic high-risk phenotype within IMS-IMWG 2025 staging in newly diagnosed multiple myeloma.
Yating Li, Lihui Shi, Wenqiang Yan et al. · Leukemia · Sep 7, 2026 · PMID 42706314 · candidate dictionary pubmed
Myeloma engraftment suppresses osteocytic ossification signatures rescued by loading in mice and reveals predictors of patient outcome.
Fani Ziouti, Muhammad Azeem, Maximilian Rummler et al. · Bone · Sep 7, 2026 · PMID 42705405 · candidate dictionary pubmed
Activating a novel cell death pathway to target PI-resistant multiple myeloma and enhance immunogenic cell death.
Xinyun Zhang, Zhiming Wang, Yilei Shi et al. · Apoptosis · Sep 7, 2026 · PMID 42704369 · candidate dictionary pubmed
Machine Learning-Derived Immune Gene Signature Predicts Prognosis and Therapeutic Vulnerabilities in Multiple Myeloma.
Kai Wang, Chenfei Zhao, Jingru Shi et al. · Cancer Sci · Sep 6, 2026 · PMID 42702361 · candidate

dictionary

pubmed

MRD-guided induction-intensification with daratumumab-carfilzomib-based regimen followed by ASCT in patients with newly diagnosed multiple myeloma.

Daizo Yokoyama, Daisuke Minakata, Shin-Ichiro Fujiwara et al. · Leuk Lymphoma · Sep 6, 2026 · PMID 42702057 · candidate dictionary pubmed

Inflammatory bone marrow microenvironment impairs the therapeutic effect of daratumumab-lenalidomide in multiple myeloma.

Wenwen Cheng, Silvia Gaggero, Lama Hasan Bou Issa et al. · Biomark Res · Sep 5, 2026 · PMID 42701201 · candidate dictionary pubmed

Role of direct-acting antivirals in people with HIV-associated non-Hodgkin lymphoma and concomitant HCV infection: A study on behalf of the Fondazione Italiana Linfomi.

Michele Merli, Benedetta Bianchi, Michele Bibas et al. · Br J Haematol · Sep 4, 2026 · PMID 42697852 · candidate dictionary pubmed

Newest glue degrader nabs multiple myeloma approval.

Asher Mullard · Nat Rev Drug Discov · Sep 4, 2026 · PMID 42697955 · candidate dictionary pubmed

Genomic staging in myeloma: The need for population-specific validation.

Curtis Marcoux, Alfredo De la Torre, Darrell White · Br J Haematol · Sep 4, 2026 · PMID 42695571 · candidate dictionary pubmed

Classic Hodgkin lymphoma showing interfollicular and intrasinusoidal involvement.

Pichayut Nithagon, Annapurna Saksena · Blood · Sep 3, 2026 · PMID 42690669 · candidate dictionary pubmed

Allogeneic hematopoietic cell transplantation in Hodgkin lymphoma-single-center retrospective analysis.

Ville Forsström, Maija Itälä-Remes · Leuk Lymphoma · Sep 3, 2026 · PMID 42689373 · candidate dictionary pubmed

Integrating Palliative Care into Relapsed/Refractory Multiple Myeloma in the Immunotherapy Era: A Narrative Review.

Muhanad Alzahrani, Zaid Musaad Alsharif, Ziyad Alzahrani · J Pain Palliat Care Pharmacother · Sep 3, 2026 · PMID 42693623 · candidate dictionary pubmed

FASTINA - protocol for a randomised feasibility trial of time-restricted eating to improve response to multiple myeloma therapy.

Anna Franziska Hamm, Jan Vorwerk, Mona Maria Merz et al. · Pilot Feasibility Stud · Sep 3, 2026 · PMID 42693457 · candidate dictionary pubmed

Macrophage reprogramming, not CD8 T cell dynamics, characterizes durable disease control following PD-1 blockade in smoldering myeloma.

Noé Perron, Kane Foster, Tarek H Mouhieddine et al. · Leukemia · Sep 3, 2026 · PMID 42693161 · candidate dictionary pubmed

A structural framework for mutation-guided immunotherapy sequencing of GPRC5D-targeted T cell engagers in multiple myeloma.

Ricardo Ahrens, Kyra Ahrens, Maximilian Al-Bazaz et al. · Blood Cancer J · Sep 3, 2026 · PMID 42693082 · candidate dictionary pubmed

Evaluation of the UK Myeloma Research Alliance risk profile in transplant-ineligible multiple myeloma patients treated with novel agents.

Hitomi Nakayama, Tomonori Nakazato, Atsushi Takahata et al. · Br J Haematol · Sep 3, 2026 · PMID 42692463 · candidate dictionary pubmed

Machine Learning and Molecular Modeling Reveal HDAC6 as a Key Target of Tanshinone IIA in Multiple Myeloma.

Jian Gao, Jiawen Chu, Pengpeng Li · J Phys Chem B · Sep 3, 2026 · PMID 42691419 · candidate dictionary pubmed

Efficacy and safety of bridging therapy prior to CAR T-cell therapy in relapsed or refractory multiple myeloma.

Marie Christine Wesener, Uta Margareta Demel, Thomas Pabst et al. · Haematologica · Sep 3, 2026 · PMID 42687830 · candidate dictionary pubmed

Exposure-response and dose simulation of belantamab mafodotin in combination with standards of care in patients with relapsed/refractory multiple myeloma.

Sagar Lonial, Paul G Richardson, Geraldine Ferron-Brady et al. · Haematologica · Sep 3, 2026 · PMID 42687822 · candidate dictionary pubmed

Independent prognostic value of semaphorin-4D, interleukin-1β and complement activation in newly diagnosed multiple myeloma patients.

Ioannis Ntanasis-Stathopoulos, Panagiota-Efstathia Nikolaou, Charalampos Filippatos et al. · Haematologica · Sep 3, 2026 · PMID 42687818 · candidate dictionary pubmed

Fixed-duration lenalidomide maintenance: considering environmental value in multiple myeloma.

Max Piffoux, Sebastien Taillemite · Haematologica · Sep 3, 2026 · PMID 42687812 · candidate dictionary pubmed

Real-world minimal residual disease assessment in multiple myeloma using a standardized flow cytometry approach: feasibility, clinical implications, and immune correlates from a single-center experience.

Cirino Botta, Andrea Rizzuto, Maria Speciale et al. · Haematologica · Sep 3, 2026 · PMID 42687806 · candidate dictionary pubmed

Sequenced, Not Stirred: Positioning CAR T and Bispecific Antibody Therapy in Multiple Myeloma.

Rahul Banerjee · Blood Cancer Discov · Sep 3, 2026 · PMID 42593166 · candidate dictionary pubmed